In a report released on October 10, David Evans from Kepler Capital maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), ...

J.P. Morgan analyst David Adlington maintained a Buy rating on Gerresheimer (0NTI – Research Report) today and set a price target of ...

Even in areas of tech that have done better, bosses note that the war is undermining morale and productivity. What is more, ...

DKSH Healthcare Business Unit, a leading partner for healthcare companies seeking to grow their business in Asia and beyond, is excited to announce a series of initiatives across Asia in observance of ...

Cooper’s pricing power and cost optimization efforts are expected to drive margin expansion. Read why I reiterate a Buy ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Kiniksa Pharmaceuticals Ltd. is a biopharmaceutical company, which engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating ...

In the life sciences industry in particular, leading pharma companies are already deploying this technology across their own operations to spur productivity and efficiency for mundane, time ...

Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing and commercializing novel medicines for patients living with rare diseases including Lambert-Eaton ...

Combination corticosteroid-antibiotic preparations, such as TobraDex ® (tobramycin 0.3%/dexamethasone 0.1%) (Alcon, Ft. Worth, TX), and Maxitrol ® (dexamethasone, neomycin, and polymyxin B ...